{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:03:30Z","timestamp":1787853810132,"version":"build-2784847793"},"reference-count":54,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00349"],"award-info":[{"award-number":["PI20\/00349"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00065"],"award-info":[{"award-number":["PI16\/00065"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00261"],"award-info":[{"award-number":["PI18\/00261"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00352"],"award-info":[{"award-number":["PI22\/00352"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo Europeo de Desarrollo Regional (FEDER)","award":["PI20\/00349"],"award-info":[{"award-number":["PI20\/00349"]}]},{"name":"Fondo Europeo de Desarrollo Regional (FEDER)","award":["PI16\/00065"],"award-info":[{"award-number":["PI16\/00065"]}]},{"name":"Fondo Europeo de Desarrollo Regional (FEDER)","award":["PI18\/00261"],"award-info":[{"award-number":["PI18\/00261"]}]},{"name":"Fondo Europeo de Desarrollo Regional (FEDER)","award":["PI22\/00352"],"award-info":[{"award-number":["PI22\/00352"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sarcopenia is a frequent comorbidity of rheumatoid arthritis (RA). Clinical trials have shown that JAK inhibitors (JAKi) produce an asymptomatic increase in serum creatine kinase (CK) in RA, suggesting an impact on muscle. We evaluated the effect of JAKi in muscle remodeling in an experimental RA model. Antigen-induced arthritis (experimental RA, e-RA) was performed in 14 rabbits. Seven rabbits received tofacitinib (TOFA, orally 10 mg\/kg\/day). Animals were euthanized one day after the last ovalbumin injection, and muscles were prepared for histology, RT-PCR, and WB. C-reactive protein (CRP) and Myostatin (MSTN) serum concentration were determined by ELISA. Creatine and creatine kinase (CK) were analyzed. An increase in body weight as well as tibialis anterior cross-sectional area and diameter was observed in e-RA+TOFA vs. e-RA. e-RA decreased type II fibers and increased the myonuclei number, with all reverted by TOFA. TOFA did not modify CRP levels, neither did MSTN. TOFA significantly reduced IL-6, atrogin-1, and MuRF-1 compared with e-RA. e-RA+TOFA showed higher CK and lower creatine levels compared with e-RA. No differences in PAX-7 were found, while TOFA prevented the increase in MyoD1 in e-RA. Our model reflects the features of rheumatoid sarcopenia in RA. JAKi increased muscle mass through attenuating IL-6\/JAK\/STAT activation, decreasing atrogenes, and restoring muscle differentiation markers. These data together with an increase in CK support the role of CK as a valuable marker of muscle gain following JAKi treatment.<\/jats:p>","DOI":"10.3390\/ijms241713181","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:06:48Z","timestamp":1692871608000},"page":"13181","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of Tofacitinib on Muscle Remodeling in Experimental Rheumatoid Sarcopenia"],"prefix":"10.3390","volume":"24","author":[{"given":"Ismael","family":"Bermejo-\u00c1lvarez","sequence":"first","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-0148","authenticated-orcid":false,"given":"Sandra","family":"P\u00e9rez-Baos","sequence":"additional","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gratal","sequence":"additional","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Medina","sequence":"additional","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-2944","authenticated-orcid":false,"given":"Raquel","family":"Largo","sequence":"additional","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3241-991X","authenticated-orcid":false,"given":"Gabriel","family":"Herrero-Beaumont","sequence":"additional","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-574X","authenticated-orcid":false,"given":"Ar\u00e1nzazu","family":"Mediero","sequence":"additional","affiliation":[{"name":"Bone and Joint Research Unit, Rheumatology Department, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz UAM, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.berh.2007.06.002","article-title":"Comorbidities in Rheumatoid Arthritis","volume":"21","author":"Michaud","year":"2007","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/03009742.2021.1973678","article-title":"Rheumatoid Cachexia in Early Rheumatoid Arthritis: Prevalence and Associated Variables","volume":"52","year":"2023","journal-title":"Scand. J. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: Pathophysiology and Clinical Relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jcsm.12320","article-title":"Prevalence of Rheumatoid Cachexia in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis: Systematic Review of RA Cachexia Prevalence","volume":"9","author":"Santo","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms Regulating Skeletal Muscle Growth and Atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and Skeletal Muscle Wasting During Cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/rheumatology\/kew243","article-title":"Tight Control of Disease Activity Fails to Improve Body Composition or Physical Function in Rheumatoid Arthritis Patients","volume":"55","author":"Lemmey","year":"2016","journal-title":"Rheumathology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/gerona\/glt184","article-title":"The \u201cCytokine for Gerontologists\u201d Has Some Company","volume":"69","author":"Roubenoff","year":"2014","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK \/ STAT Pathway in Skeletal Muscle Pathophysiology","volume":"10","author":"Moresi","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/002215540205001202","article-title":"In Vivo Activation of STAT3 Signaling in Satellite Cells and Myofibers in Regenerating Rat Skeletal Muscles","volume":"50","author":"Kami","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1152\/ajpcell.00574.2001","article-title":"Multiple Signaling Pathways Mediate LIF-Induced Skeletal Muscle Satellite Cell Proliferation","volume":"283","author":"Spangenburg","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2008.12.015","article-title":"STAT3 Induces Muscle Stem Cell Differentiation by Interaction with MyoD","volume":"46","author":"Yang","year":"2009","journal-title":"Cytokine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1111\/febs.12338","article-title":"Interleukin-6 Myokine Signaling in Skeletal Muscle: A Double-Edged Sword?","volume":"280","author":"Scheele","year":"2013","journal-title":"FEBS J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1083\/jcb.200703184","article-title":"JAK1-STAT1-STAT3, a Key Pathway Promoting Proliferation and Preventing Premature Differentiation of Myoblasts","volume":"179","author":"Sun","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1038\/s41598-017-06581-6","article-title":"Compensatory Anabolic Signaling in the Sarcopenia of Experimental Chronic Arthritis","volume":"7","author":"Little","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"960363","DOI":"10.1155\/2012\/960363","article-title":"Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J. Nutr. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1113\/jphysiol.2008.151027","article-title":"Phosphocreatine as an Energy Source for Actin Cytoskeletal Rearrangements during Myoblast Fusion: Phosphocreatine Regulates Cell Fusion","volume":"586","author":"Steeds","year":"2008","journal-title":"J. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1113\/jphysiol.2008.155358","article-title":"The Phosphocreatine-Creatine Kinase System Helps to Shape Muscle Cells and Keep Them Healthy and Alive","volume":"586","author":"Saks","year":"2008","journal-title":"J. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS Guidelines on the Diagnostic Approach to Pauci- or Asymptomatic HyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","article-title":"Approach to Asymptomatic Creatine Kinase Elevation","volume":"83","author":"Oddis","year":"2016","journal-title":"CCJM"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1007\/s10620-020-06560-4","article-title":"Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials","volume":"66","author":"Panaccione","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10067-019-04833-6","article-title":"Symptomatic Elevation Creatine Kinase Following Treatment of Rheumatoid Arthritis with Baricitinib","volume":"39","author":"Anjara","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.23719","article-title":"Abnormal Body Composition Phenotypes in Older Rheumatoid Arthritis Patients: Association with Disease Characteristics and Pharmacotherapies","volume":"59","author":"Giles","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar4673","article-title":"Changes in Serum Creatinine in Patients with Active Rheumatoid Arthritis Treated with Tofacitinib: Results from Clinical Trials","volume":"16","author":"Isaacs","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/bjd.13551","article-title":"Tofacitinib Withdrawal and Retreatment in Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized Controlled Trial","volume":"172","author":"Bissonnette","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1476-5381.2010.00957.x","article-title":"Pharmacological Modulation by Celecoxib of Cachexia Associated with Experimental Arthritis and Atherosclerosis in Rabbits: PGE2 Inhibition in RA-Associated Cachexia","volume":"161","author":"Romero","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13539-013-0102-1","article-title":"Temporal Development of Muscle Atrophy in Murine Model of Arthritis Is Related to Disease Severity","volume":"4","author":"Filippin","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2009.05.017","article-title":"IGF-I System, Atrogenes and Myogenic Regulatory Factors in Arthritis Induced Muscle Wasting","volume":"309","author":"Castillero","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin Reduces Akt\/TORC1\/P70S6K Signaling, Inhibiting Myoblast Differentiation and Myotube Size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"684965","DOI":"10.1155\/2015\/684965","article-title":"Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease","volume":"2015","author":"Wang","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vainshtein, A., and Sandri, M. (2020). Signaling Pathways That Control Muscle Mass. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134759"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"785712","DOI":"10.3389\/fcell.2021.785712","article-title":"Regulation of Myostatin on the Growth and Development of Skeletal Muscle","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00125-015-3822-2","article-title":"Muscle-Specific Inflammation Induced by MCP-1 Overexpression Does Not Affect Whole-Body Insulin Sensitivity in Mice","volume":"59","author":"Oteng","year":"2016","journal-title":"Diabetologia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.1038\/s41598-020-68769-7","article-title":"Chemokine C\u2013C Motif Ligand 2 Overexpression Drives Tissue-Specific Metabolic Responses in the Liver and Muscle of Mice","volume":"10","author":"Camps","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/japplphysiol.01399.2010","article-title":"LIF Is a Contraction-Induced Myokine Stimulating Human Myocyte Proliferation","volume":"111","author":"Broholm","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","article-title":"Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy","volume":"7","author":"Serrano","year":"2008","journal-title":"Cell Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cmet.2011.12.001","article-title":"Srf-Dependent Paracrine Signals Produced by Myofibers Control Satellite Cell-Mediated Skeletal Muscle Hypertrophy","volume":"15","author":"Guerci","year":"2012","journal-title":"Cell Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/hmg\/ddx083","article-title":"Impaired Fetal Muscle Development and JAK-STAT Activation Mark Disease Onset and Progression in a Mouse Model for Merosin-Deficient Congenital Muscular Dystrophy","volume":"26","author":"Nunes","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"34029","DOI":"10.1074\/jbc.M803012200","article-title":"JAK2\/STAT2\/STAT3 Are Required for Myogenic Differentiation","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"44178","DOI":"10.1074\/jbc.M304884200","article-title":"Reciprocal Inhibition between MyoD and STAT3 in the Regulation of Growth and Differentiation of Myoblasts","volume":"278","author":"Kataoka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","article-title":"Inhibitors of Cytokine Signal Transduction","volume":"279","author":"Wormald","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1096-6374(02)00135-1","article-title":"Growth Impairment in IL-6-Overexpressing Transgenic Mice Is Associated with Induction of SOCS3 MRNA","volume":"13","author":"Lieskovska","year":"2003","journal-title":"Growth Horm. IGF Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 Pathway Inhibition Blocks Skeletal Muscle Wasting Downstream of IL-6 and in Experimental Cancer Cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12950-019-0206-2","article-title":"Inhibition of PSTAT1 by Tofacitinib Accounts for the Early Improvement of Experimental Chronic Synovitis","volume":"16","author":"Gratal","year":"2019","journal-title":"J. Inflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fphys.2018.00409","article-title":"Mediators and Patterns of Muscle Loss in Chronic Systemic Inflammation","volume":"9","author":"Largo","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-022-02858-y","article-title":"The Effect of Disease-Modifying Anti-Rheumatic Drugs on Skeletal Muscle Mass in Rheumatoid Arthritis Patients: A Systematic Review with Meta-Analysis","volume":"24","author":"Hein","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.22540\/JFSF-08-053","article-title":"The Rheumatoid Arthritis and MUScle (RAMUS) Study: Protocol for an Observational Single-Arm Study of Skeletal Muscle in Patients with Rheumatoid Arthritis Receiving Tofacitinib","volume":"8","author":"Bennett","year":"2023","journal-title":"J. Frailty Sarcopenia Falls"},{"key":"ref_49","first-page":"603","article-title":"Low Serum Creatine Kinase Activity Is Associated with Muscle Weakness in Patients with Rheumatoid Arthritis","volume":"23","author":"Stucki","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/15685690260494834","article-title":"Serum Creatine Kinase Levels as Inflammatory Marker in Patients with Rheumatoid Arthritis","volume":"14","author":"Yildirim","year":"2002","journal-title":"Pain Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s100670070049","article-title":"Serum Creatine Kinase in Patients with Rheumatic Diseases","volume":"19","author":"Lee","year":"2000","journal-title":"Clin. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2217\/bmm-2018-0379","article-title":"Biochemical Markers of Muscle Damage and High Serum Concentration of Creatine Kinase in Patients on Statin Therapy","volume":"13","author":"Nogueira","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/33.3.231","article-title":"Reduced Activity of Serum Creatine Kinase in Rheumatoid Arthritis: A Phenomenon Linked to the Inflammatory Response","volume":"33","author":"Collado","year":"1994","journal-title":"Br. J. Rheumatol."},{"key":"ref_54","first-page":"e50074","article-title":"Isolation and Culture of Individual Myofibers and Their Satellite Cells from Adult Skeletal Muscle","volume":"73","author":"Pasut","year":"2013","journal-title":"J. Vis. Exp."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13181\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:38:25Z","timestamp":1760128705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":54,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241713181"],"URL":"https:\/\/doi.org\/10.3390\/ijms241713181","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}